Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Burke

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Trials|January 20, 2018
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trialRoberta W Scherer, Lea Drye, Jacobo Mintzer, et al.
Immunology Letters|January 11, 2025
Post hoc analysis: 6 Months immunogenicity after third dose of BNT162b2 vs JNJ-78,436,735 after two doses of BNT162b2 vaccine in solid organ transplant recipientsYoichiro Natori, Eric Martin, Adela Mattiazzi, et al.
JAMA Neurology|September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical TrialJacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
Journal of the American Society of Nephrology : JASN|June 14, 2014
Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular diseaseTae-Hyun Yoo, Christopher E Pedigo, Johanna Guzman, et al.
Gynecologic Oncology|June 14, 2020
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 PandemicAmanda N Fader, Warner K Huh, Joshua Kesterson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2023
A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant RecipientsYoichiro Natori, Eric Martin, Adela Mattiazzi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Trials|January 20, 2018
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trialRoberta W Scherer, Lea Drye, Jacobo Mintzer, et al.
Immunology Letters|January 11, 2025
Post hoc analysis: 6 Months immunogenicity after third dose of BNT162b2 vs JNJ-78,436,735 after two doses of BNT162b2 vaccine in solid organ transplant recipientsYoichiro Natori, Eric Martin, Adela Mattiazzi, et al.
JAMA Neurology|September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical TrialJacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
Journal of the American Society of Nephrology : JASN|June 14, 2014
Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular diseaseTae-Hyun Yoo, Christopher E Pedigo, Johanna Guzman, et al.
Gynecologic Oncology|June 14, 2020
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 PandemicAmanda N Fader, Warner K Huh, Joshua Kesterson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2023
A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant RecipientsYoichiro Natori, Eric Martin, Adela Mattiazzi, et al.
Pageof 4